| Concomitant |
| Product Used For Unknown Indication |
9.8% |
| Contraception |
9.3% |
| Mantle Cell Lymphoma Stage Iii |
9.0% |
| Premenstrual Syndrome |
8.7% |
| Pain |
8.1% |
| Headache |
6.2% |
| Depression |
5.6% |
| Acne |
5.1% |
| Nausea |
4.5% |
| Premedication |
4.5% |
| Migraine |
4.2% |
| Hypertension |
3.9% |
| Pneumonia Mycoplasmal |
3.9% |
| Follicle Centre Lymphoma, Follicular Grade I, Ii, Iii Stage Iv |
3.1% |
| Sleep Disorder |
2.8% |
| Congenital Infection |
2.2% |
| Gastrooesophageal Reflux Disease |
2.2% |
| Metastatic Renal Cell Carcinoma |
2.2% |
| Prophylaxis |
2.2% |
| Sepsis |
2.2% |
|
| Pain |
12.9% |
| White Blood Cell Count Decreased |
9.7% |
| Pulmonary Embolism |
8.1% |
| Cholelithiasis |
4.8% |
| Deep Vein Thrombosis |
4.8% |
| Haemolysis |
4.8% |
| Injury |
4.8% |
| Oedema Peripheral |
4.8% |
| Pulmonary Infarction |
4.8% |
| Rhabdomyolysis |
4.8% |
| Surgery |
4.8% |
| Tooth Loss |
4.8% |
| Anxiety |
3.2% |
| Blood Pressure Increased |
3.2% |
| Cerebrovascular Accident |
3.2% |
| Cholecystitis Chronic |
3.2% |
| Convulsion |
3.2% |
| Cystitis Haemorrhagic |
3.2% |
| Diarrhoea |
3.2% |
| Emotional Distress |
3.2% |
|
